Omeprazole 20mg Capsule
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Children's Hospital of Philadelphia
Overview
Omeprazole 20mg Capsule is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Omeprazole 20mg Capsule clinical trials
Explore related
Medical disclaimer. This page summarizes research about Omeprazole 20mg Capsule for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.